Concepedia
Statistics
Publications
25
Citations
2.5K
H-Index
18
Active since
1975
Affiliations
Wythenshawe Hospital(Current)
Medicines Evaluation Unit
University of Manchester
Manchester University
GlaxoSmithKline (United Kingdom)
Stephen J. Langley is an author at Wythenshawe Hospital specializing in pharmacology, pharmacy, and bronchodilator therapy.
Publications per year
1975–2010
Effect of SCH55700, a Humanized Anti-Human Interleukin-5 Antibody, in Severe Persistent Asthma: A Pilot Study
Johan Kips, Brian O’Connor, Stephen J. Langley et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 497 citations
Pharmacy, Pharmacokinetics, Pharmacology +15
A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol
James F. Donohue, J.A. van Noord, Eric Bateman et al. · CHEST Journal · 2002 · 469 citations
Medicine, Clinical Sciences, Pharmacotherapy +10
Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study
Clare Murray, Ashley Woodcock, Stephen J. Langley et al. · The Lancet · 2006 · 354 citations
Medicine, Child Health, Pediatrics +16
Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study
Martin Brutsche, Ingrid Carlen Brutsche, Mohamed Munawar et al. · The Lancet · 2000 · 223 citations
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction
César Villarán, Shane O’Neill, Arthur Helbling et al. · Journal of Allergy and Clinical Immunology · 1999 · 181 citations · Full text
Pharmacy, Clinical Sciences, Pharmacotherapy +14
1–5 of 25